American Journal of Kidney Diseases
Volume 37, Issue 5 , Pages 1004-1010, May 2001

Prevalence of infected patients and understaffing have a rolein hepatitis C virus transmission in dialysis*

    MD
  • Nicola Petrosillo

      Affiliations

    • National Institute for Infectious Diseases, IRCCSLazzaro Spallanzani: Istituto Superiore di Sanità, Rome, Italy
    • Divisione di Nefrologia e Dialisi, Ospedale di Ferrara, Ferrara, Italy
    • Dipartimento di Clinica Medica, Immunologia e Malattie Infettive, University di Bari; and Regione Emilia Romagna, Bologna, Italy
    • Corresponding Author InformationAddress reprint requests to Nicola Petrosillo, MD, IRCCSLazzaro Spallanzani, Via Portuense 292, 00149 Rome, Italy.
  • , MD
  • Paolo Gilli

      Affiliations

    • National Institute for Infectious Diseases, IRCCSLazzaro Spallanzani: Istituto Superiore di Sanità, Rome, Italy
    • Divisione di Nefrologia e Dialisi, Ospedale di Ferrara, Ferrara, Italy
    • Dipartimento di Clinica Medica, Immunologia e Malattie Infettive, University di Bari; and Regione Emilia Romagna, Bologna, Italy
  • , MD
  • Diego Serraino

      Affiliations

    • National Institute for Infectious Diseases, IRCCSLazzaro Spallanzani: Istituto Superiore di Sanità, Rome, Italy
    • Divisione di Nefrologia e Dialisi, Ospedale di Ferrara, Ferrara, Italy
    • Dipartimento di Clinica Medica, Immunologia e Malattie Infettive, University di Bari; and Regione Emilia Romagna, Bologna, Italy
  • , MD
  • Pietro Dentico

      Affiliations

    • National Institute for Infectious Diseases, IRCCSLazzaro Spallanzani: Istituto Superiore di Sanità, Rome, Italy
    • Divisione di Nefrologia e Dialisi, Ospedale di Ferrara, Ferrara, Italy
    • Dipartimento di Clinica Medica, Immunologia e Malattie Infettive, University di Bari; and Regione Emilia Romagna, Bologna, Italy
  • , MD
  • Alfonso Mele

      Affiliations

    • National Institute for Infectious Diseases, IRCCSLazzaro Spallanzani: Istituto Superiore di Sanità, Rome, Italy
    • Divisione di Nefrologia e Dialisi, Ospedale di Ferrara, Ferrara, Italy
    • Dipartimento di Clinica Medica, Immunologia e Malattie Infettive, University di Bari; and Regione Emilia Romagna, Bologna, Italy
  • , MD
  • Pietro Ragni

      Affiliations

    • National Institute for Infectious Diseases, IRCCSLazzaro Spallanzani: Istituto Superiore di Sanità, Rome, Italy
    • Divisione di Nefrologia e Dialisi, Ospedale di Ferrara, Ferrara, Italy
    • Dipartimento di Clinica Medica, Immunologia e Malattie Infettive, University di Bari; and Regione Emilia Romagna, Bologna, Italy
  • , MD
  • Vincenzo Puro

      Affiliations

    • National Institute for Infectious Diseases, IRCCSLazzaro Spallanzani: Istituto Superiore di Sanità, Rome, Italy
    • Divisione di Nefrologia e Dialisi, Ospedale di Ferrara, Ferrara, Italy
    • Dipartimento di Clinica Medica, Immunologia e Malattie Infettive, University di Bari; and Regione Emilia Romagna, Bologna, Italy
  • , ScD
  • Caterina Casalino

      Affiliations

    • National Institute for Infectious Diseases, IRCCSLazzaro Spallanzani: Istituto Superiore di Sanità, Rome, Italy
    • Divisione di Nefrologia e Dialisi, Ospedale di Ferrara, Ferrara, Italy
    • Dipartimento di Clinica Medica, Immunologia e Malattie Infettive, University di Bari; and Regione Emilia Romagna, Bologna, Italy
  • , MD
  • Giuseppe Ippolito

      Affiliations

    • National Institute for Infectious Diseases, IRCCSLazzaro Spallanzani: Istituto Superiore di Sanità, Rome, Italy
    • Divisione di Nefrologia e Dialisi, Ospedale di Ferrara, Ferrara, Italy
    • Dipartimento di Clinica Medica, Immunologia e Malattie Infettive, University di Bari; and Regione Emilia Romagna, Bologna, Italy
  • ,
  • Collaborative Group

Received 14 August 2000; accepted 8 December 2000.

Abstract 

To assess hepatitis C virus (HCV) incidence rates and identify determinants of infection among hemodialysis patients, a multicenter study was conducted in 58 units in Italy. An initial seroprevalence survey was conducted among 3,492 patients already on hemodialysis therapy as of January 1997 and among an additional 434 patients who began dialysis up to January 1998. HCV antibodies were assessed by third-generation enzyme Immunoassays. Patients testing seronegative at baseline were enrolled Into a 1-year incidence study with serological follow-up at 6 and 12 months. For patients who seroconverted, an HCV RNA assay was performed on stored baseline samples to confirm new infection. A nested case-control study was subsequently performed to Investigate potential risk factors. For each incident case, three controls negative for both HCV antibodies and HCV RNA were randomly selected. At enrollment, HCV seroprevalence was 30.0%. During follow-up, 23 new HCV cases were documented, with a cumulative incidence of 9.5 cases/1,000 patient-years. By logistic regression analysis, an increased risk for HCV infection emerged for patients attending the dialysis units with a high prevalence of HCV-infected patients at baseline (odds ratio [OR], 4.6) and for those attending units with a low personnel-patient ratio (OR, 5.4). Among extradialysis factors, a history of surgical Intervention in the previous 6 months (OR, 16.7) significantly Increased HCV risk. These findings suggest that the combination of understaffing and a high level of Infected patients in the dialysis setting increases the risk for HCV nosocomial transmission. This is likely related to an increased likelihood for breaks in infection control measures.

Supported in part by the Progetto Epatite Vrale-ISS(D.L.vo 30/12/1992 n. 502), and Ricerca Corrente-IRCCS Spallanzani.

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

* For the Collaborative Group (members in Appendix).

PII: S0272-6386(05)80017-4

American Journal of Kidney Diseases
Volume 37, Issue 5 , Pages 1004-1010, May 2001